Apogee Therapeutics prices upsized $350M offering at $70 a share

AI Briefing

• – Apogee Therapeutics upsized its IPO, pricing 5M shares at $70, for $350M in gross proceeds.
• – The offering was originally smaller, but was increased to meet strong demand.
• – The company will use the funds for various uses, including research and development.